Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids
This study has been completed.
Study NCT01452659   Information provided by Takeda Global Research & Development Center, Inc.

First Received on August 31, 2011.   Last Updated on January 17, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Uterine Fibroids
Additional conditions recognized in this trial
Leiomyoma
Myofibroma
More general conditions related to this trial
Connective Tissue Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Muscle Tissue
Interventions listed in this trial
TAK-385
Placebo
Sponsors listed in this trial
Takeda Pharmaceutical Company Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services